The nonclassical progesterone receptors progesterone receptor membrane component (PGRMC) 1 and PGRMC2 have been implicated in regulating cell survival of endometrial and ovarian cells in vitro and are abundantly expressed in these cell types. The objective of this study was to determine if Pgrmc1 and Pgrmc2 are essential for normal female reproduction. P rogesterone (P4) is a female sex steroid that regulates tissue homeostasis and is essential for reproduction in the female. Disrupted P4 signaling is causally coupled to many reproductive diseases that result in subfertility or infertility, including leiomyomas, endometriosis, irregular menstrual bleeding, miscarriage, and preterm labor (1-9). In the United States, over 10% of women have impaired fecundity (10), and another 10% of women of reproductive age are clinically diagnosed with endometriosis (11). Infertility and reproductive diseases like endometriosis are multifaceted and difficult to successfully treat. Understanding the etiology of these diseases and how impaired P4 signaling contributes to their pathogenesis is necessary for developing more effective therapeutic approaches.
P rogesterone (P4) is a female sex steroid that regulates tissue homeostasis and is essential for reproduction in the female. Disrupted P4 signaling is causally coupled to many reproductive diseases that result in subfertility or infertility, including leiomyomas, endometriosis, irregular menstrual bleeding, miscarriage, and preterm labor (1) (2) (3) (4) (5) (6) (7) (8) (9) . In the United States, over 10% of women have impaired fecundity (10) , and another 10% of women of reproductive age are clinically diagnosed with endometriosis (11) . Infertility and reproductive diseases like endometriosis are multifaceted and difficult to successfully treat. Understanding the etiology of these diseases and how impaired P4 signaling contributes to their pathogenesis is necessary for developing more effective therapeutic approaches.
Much of what is known about P4 actions is centered on the classical progesterone receptor (PGR). However, several putative nonclassical PGRs have been identified, and these include 3 members of the progestin and adipoQ receptor family (12, 13) and 2 members of the progesterone receptor membrane component (PGRMC) family in PGRMC1 and PGRMC2 (14) (15) (16) (17) . Importantly, although in vitro studies using both primary and transformed reproductive cell lines that lack expression of PGR have established that PGRMC1 mediates at least some of the actions of P4, parallel findings have yet to be confirmed in vivo. As evaluated in several species, PGRMC1 and PGRMC2 are expressed throughout the female reproductive tract in both the nongravid state and during pregnancy (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . Aberrant expression of PGRMC1 and PGRMC2 has been implicated in female reproductive diseases. These cumulative findings conceptually indicate that homeostatic expression of PGRMC1 and PGRMC2 is essential for normal female reproductive physiology and maintenance of reproductive tissue homeostasis. Recent findings from our laboratory demonstrate that conditional ablation of Pgrmc1 from the uterus results in subfertility in female mice (30) . These animals are subfertile at the time of sexual maturation, but then also develop endometrial cysts at 4 to 5 months of age. This phenotype is consistent with premature aging of the reproductive tract. Given that, as with PGRMC1, PGRMC2 is highly expressed in the uterus, the objective of this study was to evaluate the functional contribution of PGRMC2 to female reproduction. To accomplish this, we developed mutant mice in which Pgrmc2 alone or in combination with Pgrmc1 were conditionally ablated from the female reproductive tract to assess the function of these 2 genes in female fertility.
Materials and Methods

Floxing the Pgrmc2 allele and genotyping
All procedures involving animals were approved by the Institutional Animal Care and Use Committees at Washington State University or the University of Connecticut Health Center. A Pgrmc2-targeting vector was prepared by recombineering according to Lee et al. (31) . Briefly, a 13.6-kb section of the Pgrmc2 genomic sequence containing both exon 2 and exon 3, as well as 4 kb of the 3 0 -downstream sequences, was retrieved from the bacterial artificial chromosome, RP23-2C23, into pPL253 by gap repair. A 
Animals and treatments
Six-month fertility trials were completed for Pgrmc2 and Pgrmc1/2 mouse colonies on a Pgr-cre background in which 6-week-old control (Pgrmc2 fl/fl and Pgrmc1/2 fl/fl ) and conditionally mutant (Pgrmc2
) female mice were placed with males of proven fertility. Six female mice were included in each colony for each genotype. Through the duration of the fertility trials, the following information was recorded for each litter: date of birth, number of pups born, number of pups surviving to weaning, pup weights on postnatal days 5 and 21, number of days between parity, number of litters throughout the breeding trial, and number of surviving male and female pups. Female reproductive tracts were collected from mice at the end of the breeding trials, as well as from young and aged nulliparous female mice, for histological analyses.
To evaluate estrogen receptor (ESR1) and PGR expression, uterine tissues were obtained from Pgrmc1/2 fl/fl and Pgrmc1/2
(Pgr-cre) synchronized mice under the following regimen. Sexually mature female mice were ovariectomized, rested for 1 week, and then given daily subcutaneous injections of estradiol (E2, 100 ng) diluted in sesame oil for 3 consecutive days. After a 2-day rest, mice were treated with P4 (1 mg) for 2 days and then E2 plus P4 for 1 day. Uterine tissues were collected 24 hours after the last injection and partitioned for RNA isolation and fixation in 4% paraformaldehyde (PFA) in preparation for quantitative polymerase chain reaction (qPCR) and paraffin embedding, respectively. Other mice were treated with 100 ng E2 for 2 days and then, after 4 days, were treated with 50 ng E2 and collected 18 h later. Uterine tissues were collected for RNA isolation in preparation for qPCR and 4% PFA for histology. Expression of the vascular marker PECAM1 was evaluated in Table 1 . PCR Primers
Gene Identifier Primer Sequence 
Histology and immunohistochemistry
All tissues were fixed in 4% paraformaldehyde and stored in 70% ethanol until paraffin embedding. Tissues were processed through an ethanol gradient and xylenes, embedded in paraffin, and sectioned at 5 mm. Tissue sections were deparaffinized in xylenes and rehydrated in a series of decreasing ethanol washes. Picric acid stain or hematoxylin and eosin staining (Scytek HAE-1-IFU kit, Logan, UT) were used for analysis of tissue architecture, including visualization of cytoplasmic vs nuclear morphology and histopathology analysis.
For immunohistochemistry, rehydrated tissue sections underwent quenching (10 minutes in 8% hydrogen peroxide) and antigen retrieval (boiling for 3 minutes in 0.1M sodium citrate followed by incubation in the heated solution for 20 minutes and then cooling to room temperature). Sections were then blocked (0.1% bovine serum albumin, 0.1% normal goat serum, and 1% Triton-X100 in phosphate-buffered saline) for 1 hour at room temperature and incubated overnight at 4°C in blocking solution containing primary antibody as outlined in Table 2 . Slides were then washed in phosphate-buffered saline (3 x 10 minutes) and incubated with biotinylated secondary antibody for 45 minutes at room temperature. Slides were washed as before and then incubated with horseradish peroxidase-conjugated streptavidin (Vector Laboratories, Burlingame, CA). After a third series of washes, sections were incubated with 3,3 0 -diaminobenzidine substrate (BD Biosciences, San Diego, CA). Sections were counterstained with hematoxylin, dehydrated in an ethanol gradient and xylenes, and mounted. The specificity of the secondary antibody was confirmed by incubating some sections with nonimmune immunoglobulin G or omitting the primary antibody. The E2 +P4-synchronized uteri were stained for ESR1 and PGR expression using the antibodies listed in Table 2 . Uterine natural killer cell recruitment to the uterine mesometrial compartment of Pgrmc2 fl/fl and Pgrmc2 d/d female mice on DOP6 was evaluated by histochemical staining using biotinylated Dolichos biflorus agglutinin (DBA) lectin (Sigma). Thin sections were prepared as described earlier for immunohistochemistry with the exception that primary and secondary antibodies were replaced by incubation with DBA lectin (10 mg/mL) for 1 hour at room temperature.
Transmission Electron Microscopy
For transmission electron microscopy (TEM), tissues were fixed in 2.5% glutaraldehyde in 0.1M phosphate overnight at 4°C, rinsed in 0.1M phosphate, and postfixed in 1% osmium tetroxide overnight. Tissues were then dehydrated with a decreasing gradient of ethanol, infiltrated with acetone:Spurr reagent overnight followed by Spurr overnight, and embedded in resin. Finally, the resin was polymerized and cured by baking at 65°C overnight. Tissues were then sectioned, and TEM images were taken at the Franceschi Microscopy and Imaging Center at Washington State University on a FEI Tecnai G2 20 Twin equipped with a 200-kV LaB6 electron source and a 4K Eagle camera.
Data analyses
Animals were randomly assigned to the various treatment groups. Unless otherwise noted, all data are presented as the mean 6 standard error of the mean for n = 3 to 6. Individual animals represent a single experimental replicate within each experiment. Differences between treatment groups were assessed by Student t test, where the mean values of 2 groups were compared. A 2-way analysis of variance was used to identify treatment effects in the breeding trials followed by a Bonferroni posttest. All data were analyzed using GraphPad 5.0 software (San Diego, CA) where P # 0.05 was considered statistically significant.
Results
Conditional ablation of Pgrmc2 or Pgrmc1/2 results in postimplantation embryonic death
Because PGRMC1 and PGRMC2 are expressed and regulated in the uterus, we hypothesized that they play an essential role in normal pregnancy. To test this hypothesis, the Pgrmc2 allele was floxed by insertion of loxP sites before exon 2 and after exon 3 [ Fig. 1(A) ]. Pgrmc2 alone or in combination with Pgrmc1 was conditionally ablated from the female reproductive tract using the tissue-specific Pgr-cre transgenic mouse. A PCR-based genotyping protocol was developed to identify control (Pgrmc2 fl/fl ), heterozygous (Pgrmc2 fl/d ), and conditional knockout (Pgrmc2 Fig. 1(B) ; see primer sequences in Table 1 ]. A similar genotyping strategy was Second, corpora lutea (CL), which require an intact prolactin:prolactin receptor signaling pathway for P4 production, functioned normally in that serum P4 levels were not decreased during pregnancy (Fig. 4) .
To further assess the relationship between the observed subfertility in Fig. 5(D) ]. Because the embryos had died and the sites began to resorb by DOP10.5, we evaluated implantation sites on Fig. 1(B) ].
An evaluation of ovaries isolated from DOP10.5 Pgrmc2 d/d female mice revealed normal histology with large and abundant CL [ Fig. 4(A) ]. Pgrmc2 d/d females had marginally elevated serum P4 compared with Pgrmc2 fl/fl females on DOP10.5 [ Fig. 4 Fig. 7(A) ]. This is in contrast to control mice that showed greatly reduced development of endometrial cysts. Here, 20% to 30% of the mice developed cysts at 5 to 8 months of age. The cumulative incidence of cystic gland formation from all ages is shown in Fig. 7(B) . Interestingly, parity prevented cyst formation in control mice and greatly reduced the number and size of endometrial cysts in 
Discussion
We previously demonstrated the functional importance of the nonclassical progesterone receptor PGRMC1 in female reproduction, where conditional ablation from the uterus resulted in subfertility and formation of endometrial cysts (30) . The objective of the current study was to evaluate the functional contributions of the second member of the PGRMC family, PGRMC2, to female fertility. This was achieved by floxing exons 2 and 3 of the Pgrmc2 allele. The resulting transgenic mice were crossed with Pgr-cre mice to conditionally ablate Pgrmc1 and/or Pgrmc2 from the female reproductive tract. We demonstrate here that conditional ablation of Pgrmc2 alone or in combination with Pgrmc1 from the female reproductive tract initially resulted in subfertility, and this then progressed to premature reproductive senescence. It was interesting to note that Pgrmc2 d/d female mice had a more severe reproductive phenotype than Pgrmc1/2 d/d female mice, suggesting that PGRMC1 deficiency may provide some protection against reproductive failure when Pgrmc2 alone is ablated. This phenotype was accompanied by development of endometrial cysts starting around 4 months of age. This is, to our knowledge, the first functional evaluation of Pgrmc2 in an in vivo setting.
Much of what is known about members of the PGRMC family derives from in vitro studies of PGRMC1. PGRMC1 is expressed in many tissues within and outside the female reproductive system, suggesting that it has both P4-dependent and P4-independent functions as previously described (34, 35) . PGRMC1 and/or PGRMC2 are implicated in diverse cellular processes, including mitosis/cell cycle regulation (36, 37) , meiosis (23, 38, 39) , sterol metabolism (40, 41) , cell survival/antiapoptotic action (18, 42) , transcription (42, 43) , angiogenesis (44, 45) , immune regulation (46), autophagy (47) , carbon monoxide sensing (48) , and heme biosynthesis and transport (49) . It is not clear from the current study if the fertility defect observed here is due to faulty P4 signaling or if it derives from disruption of any of the cellular processes with which PGRMC family members associate. The ability to conditionally ablate Pgrmc1 and Pgrmc2 in mice should be helpful in future studies in determining how these proteins function as P4 receptors.
The PGRMC1/2-deficient mice were generated using Pgr-cre to delete Pgrmc1 and/or Pgrmc2 from female reproductive tissues, including the hypothalamus, pituitary gonadotropes, ovarian periovulatory follicles, and the majority of the female reproductive tract. Several lines of evidence suggest that the observed subfertility/infertility phenotype in Pgrmc2 d/d and Pgrmc1/2 d/d mice stems from faulty uterine function and that other elements of the reproductive system remain intact. First, the parturition interval did not differ between control and mutant mice, suggesting that estrous cyclicity and the hypothalamic-pituitary unit is normal in mutant female mice when in the presence of a male with proven breeding capacity. Second, the number of implantation sites was not different between control and mutant mice, indicating that ovulation, oviductal transport, fertilization, and implantation were normal in mutant mice. Third, a direct assessment of ovarian histology showed no difference in the presence of CL in control and mutant mice. CL from mutant mice were histologically indistinguishable from those of control mice. Fourth, CL steroidogenic functions were consistent between control and mutant mice in that midgestational serum P4 and E2 levels were not different. Finally, despite a normal number of implantation sites, we noted a significant increase in postimplantation resorptions in Pgrmc2 d/d and Pgrmc1/2 d/d female mice, indicating that embryos are able to implant, begin development, and initiate a decidual response by the mother, but then die prior to development of the placenta around DOP6 to DOP7. With the data presented here, we cannot rule out the possibility that the progression from subfertility to infertility around parities 3 or 4 in mutant mice is caused by defects in other reproductive tissues.
As demonstrated by both qPCR and immunohistochemistry, ablation of Pgrmc1/2 did not alter the expression of the classical estrogen and progesterone receptors, indicating that the observed phenotypes in these mice do not result from disrupted ESR1 or PGR activity. The uterine defect causing embryonic death occurred after the decidualization program was fully engaged, but before placentation. Decidualized stromal cells produce nutrients and growth factors to promote embryonic growth and survival. Concurrently, pregnancy modifies maternal vasculature and the maternal immune system. Modifications of maternal vasculature facilitates the delivery of nutrients to the embryo prior to placentation, while modification of the maternal immune system provides an immune-privileged site that allows the histocompatibly distinct embryo to avoid rejection. PGRMC1/2 could be involved in regulating either of these processes. During decidualization, the uterus produces and/or acquires lipid, protein, and carbohydrate nutrients from the surrounding vasculature for the developing embryo (50), thus performing placenta-like functions. PGRMC1 may be involved in this process given that it interacts with lipid/sterol metabolic enzymes that may be involved in the production of lipid nutrients. For example, PGRMC1 participates in the biosynthesis of cholesterol and other lipids through its interactions with INSIG/Scap (41, 51, 52) . Ablation of Pgrmc1/2 may prevent normal nutrient production within the decidua and transport to the embryo, thus attenuating embryonic growth and survival. The decidua produces a variety of growth factors, including vascular endothelial growth factor (VEGF), epidermal growth factor, transforming growth factor b, and others to support the embryo before placentation occurs (53) . Aberrant production of such growth factors or uncoupling of their cognate receptors may contribute to the observed postimplantation embryonic loss. Interestingly, PGRMC1 has been implicated in growth press.endocrine.org/journal/endofactor signaling in several settings. For example, PGRMC1 has now been shown by several laboratories to be necessary for the exteriorization of the epidermal growth factor receptor (EGFR) from intracellular vesicular stores to the plasma membrane (54) (55) (56) . EGFR plays an essential role in decidualization (57) . It is perhaps not surprising that the Pgrmc1/2 phenotype parallels that of the Egfr conditional mutant phenotype. The impact of Pgrmc1/2 ablation on uterine decidualization is currently under investigation. Progesterone regulates Vegf , which controls uterine decidual angiogenesis and vascular remodeling (58).
Disruption of VEGF signaling leads to postimplantation embryonic death (59) . PGRMC1 has been shown to mediate the influence of P4 on VEGF in breast cancer cells (45) and retinal glial cells (44) , and it is feasible that PGRMC1 and/or PGRMC2 are necessary for mediating P4-dependent vascular remodeling during early pregnancy. However, preliminary evaluation of the vasculature in both the nongravid and gravid uterus suggests that vascular development is not compromised by ablation of Pgrmc1/2. Progesterone is also involved in modifying the action of many components of the maternal immune system during early pregnancy (60) , and abnormalities in this process have been implicated in recurrent pregnancy loss (61) . Progesterone up-regulates the expression of PGRMC1 in immune cells in pregnant cows (46) . Although Pgrmc1 and Pgrmc2 are not ablated in immune cells when using Pgr-cre mice, aberrant P4 signaling in the uterus due to uterine ablation of Pgrmc1/2 may prevent the uterus from properly signaling immune cells to generate an appropriate immuneprivileged environment. Of note, there was a reduction in the number of uNK cells recruited to or proliferating in the mesometrial region of the implantation site. However, it is not clear if this reduction in uNK cell numbers is a direct response to PGRMC1/2 deficiency or if it occurs indirectly because of a faulty decidualization program. Further research is needed to understand why Pgrmc2 d/d and Pgrmc1/2 d/d mice have reduced fecundity and if this is due to a lack of nutrients, impaired vascularization, immune rejection of the embryo, or a combination of these factors.
PGRMC1/2 are implicated in regulating apoptosis and other processes in response to P4. There are multiple mechanisms whereby PGRMC1 could mediate the actions of P4. PGRMC1 is associated with both rapid P4 actions and changes in gene expression (18, 37) . Despite lacking a P4-binding domain homologous to that of the classical PGR, PGRMC1 still directly binds P4. This was most recently demonstrated using nuclear magnetic resonance spectroscopy showing that the cytochrome b5 domain indeed binds P4 (62) . This study supports initial receptor binding studies conducted over 15 years ago (63, 64) . PGRMC1 has also been shown to facilitate the binding of P4 to other purported P4 receptors, such as membrane progestin receptor a (mPRa) (65) . PGRMC1 may mediate P4 signaling by any number of cell signaling pathways given that it harbors several SH2 and SH3 domains, tyrosine kinase binding sites, and interaction domains for ERK1, casein kinase 2, and PDK1 (17) . Finally, PGRMC1 localizes to the nucleus to regulate gene expression in response to P4 (43). PGRMC1 does not have a DNA-binding domain; as such, PGRMC1 may function as a scaffold protein in a transcriptional complex. Further investigation is needed to understand the mechanisms by which PGRMC1 and PGRMC2 relay P4 signals to exert effects on the cell under normal uterine physiology, and if disruption in these pathways leads to uterine pathology.
Although Pgrmc2 d/d and Pgrmc1/2 d/d mice do develop endometrial cysts, this does not account for the pregnancy defect because cystic glands do not become evident until around 4 months of age despite delivery of fewer pups/litter from the first parity onward. However, the underlying molecular changes that may occur upon deletion of Pgrmc1 and/or Pgrmc2 may contribute to the initial subfertility phenotype that then later manifests in the development of cysts. The cystic glands are likely a result of faulty mesenchymal-epithelial communication.
We previously demonstrated that ablation of Pgrmc1 from the stromal, but not the epithelial compartment, results in a similar phenotype to that described for Pgrmc1 ablation from both compartments (30) . Another interesting observation is that conditional ablation of Pgrmc1, Pgrmc2, or Pgrmc1/2 results in a similar, if not identical, histological phenotype. This finding suggests that PGRMC1 and PGRMC2 function distinctly within a similar pathway to maintain normal tissue homeostasis. These glands are indicative of bland endometrial cysts in women commonly associated with atrophic endometria or senile polyps (66 press.endocrine.org/journal/endo
